The protocol aims explicitly to amplify RRV viruses and not other viruses.Alyssa Pyke designed the original assay which was published in 2011 (see below). Subsequently, Alyssa Pyke modified the reverse primer, and it is this most recent, revised version, described here.The assay targets the E2 gene region and is designed as a qualitative test for investigating RRV infection of humans and arthropods.